Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.96M Buy
86,543
+34,252
+66% +$4.18M 0.3% 82
2026
Q2
$5.92M Buy
52,291
+4,923
+10% +$488K 0.21% 87
2026
Q1
$4.47M Buy
47,368
+22,026
+87% +$2.2M 0.18% 77
2025
Q4
$2.51M Sell
25,342
-18,793
-43% -$1.82M 0.11% 116
2025
Q3
$3.74M Sell
44,135
-25,190
-36% -$1.99M 0.21% 64
2025
Q2
$4.72M Sell
69,325
-9,988
-13% -$633K 0.21% 68
2025
Q1
$4.8M Sell
79,313
-746
-0.9% -$52K 0.18% 63
2024
Q4
$5.53M Buy
+80,059
New +$5.7M 0.2% 58

Other funds holding INCY

Ruffer's INCY Position: Q3 2026 in Review

Ruffer increased its Incyte (INCY) stake by 66% in Q3 2026, buying an estimated $4.18M and bringing the position to 86,543 shares worth $5.96M. The position accounts for 0.3% of the portfolio, ranked #82.

Ruffer first reported a position in INCY in Q4 2024 and has held it in 8 quarters since. 758 funds tracked by Wall St. Rank hold INCY as of Q3 2026.

  • Ruffer held 86,543 shares of Incyte worth $5.96M as of Q3 2026.
  • Ruffer bought 34,252 Incyte shares in Q3 2026, an estimated $4.18M.
  • Incyte made up 0.3% of Ruffer's portfolio in Q3 2026, its #82 holding.
  • Ruffer first reported a position in Incyte in Q4 2024 and has held it in 8 quarters since.
  • 758 funds tracked by Wall St. Rank held Incyte as of Q3 2026.

Based on Ruffer's 13F filing for Q3 2026, filed 10 Nov 2026.